Literature DB >> 7533527

Nonrandom loss of human chromosome 3 fragments from mouse-human microcell hybrids following progressive growth in SCID mice.

S Imreh1, I Kholodnyuk, R Allikmetts, E J Stanbridge, E R Zabarovsky, G Klein.   

Abstract

Microcell hybrid lines of A9 mouse fibrosarcoma containing complete or partially deleted human chromosomes 3 (chr. 3) were inoculated into SCID mice. Cell lines derived from the tumors were examined by fluorescent in situ hybridization for the status of the transferred human chromosome and by PCR for marker loss. The SCID tumors arising after the inoculation of 10(5) cells were passaged serially in vivo and regularly showed loss of four markers; D3S1029 (3p21.3-21.2), AP20R (3p22-21.3, D3S32 (3p21.3-p21.2), and THRB (3p24). This regularly deleted region is bordered by markers GNA12 (3p21.1-p21.3) and VHL (3p25) that were maintained in a fraction of tumors. Fragments derived from the long arm of chromosome 3 and corresponding markers in the 3q26-q28 region were retained in all tumors. Our findings may be related to the postulated presence of tumor suppressor genes in the 3p24-p21 region as indicated by the frequent deletion of this region in renal and small cell lung carcinomas and other solid tumors. The technically cumbersome identification of suppressor genes may be supplemented by an "elimination test" based on analogous principles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7533527     DOI: 10.1002/gcc.2870110406

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  7 in total

1.  Mapping of a new MAP kinase activated protein kinase gene (3PK) to human chromosome band 3p21.2 and ordering of 3PK and two cosmid markers in the 3p22-p21 tumour-suppressor region by two-colour fluorescence in situ hybridization.

Authors:  A Szeles; S Bajalica-Lagercrantz; A Lindblom; T Lushnikova; V I Kashuba; S Imreh; M Nordenskjöld; G Klein; E R Zabarovsky
Journal:  Chromosome Res       Date:  1996-06       Impact factor: 5.239

2.  Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice.

Authors:  Y Yang; M Kost-Alimova; S Ingvarsson; Q Qianhui; H Kiss; A Szeles; I Kholodnyuk; A Cuthbert; G Klein; S Imreh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

3.  Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3.

Authors:  Y Cheng; N E Poulos; M L Lung; G Hampton; B Ou; M I Lerman; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

4.  Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3.

Authors:  Maria Kost-Alimova; Hajnalka Kiss; Ludmila Fedorova; Ying Yang; Jan P Dumanski; George Klein; Stefan Imreh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-08       Impact factor: 11.205

5.  The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development.

Authors:  Tyson V Sharp; Ahmad Al-Attar; Daniel E Foxler; Li Ding; Thomas Q de A Vallim; Yining Zhang; Hala S Nijmeh; Thomas M Webb; Andrew G Nicholson; Qunyuan Zhang; Aldi Kraja; Ian Spendlove; John Osborne; Elaine Mardis; Gregory D Longmore
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-05       Impact factor: 11.205

6.  LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription.

Authors:  Tyson V Sharp; Fernando Munoz; Dimitra Bourboulia; Nadege Presneau; Eva Darai; Hsei-Wei Wang; Mark Cannon; David N Butcher; Andrew G Nicholson; George Klein; Stephan Imreh; Chris Boshoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-12       Impact factor: 11.205

7.  Mandatory chromosomal segment balance in aneuploid tumor cells.

Authors:  Maria Kost-Alimova; Eva Darai-Ramqvist; Wing Lung Yau; Agneta Sandlund; Ludmila Fedorova; Ying Yang; Irina Kholodnyuk; Yue Cheng; Maria Li Lung; Eric Stanbridge; George Klein; Stefan Imreh
Journal:  BMC Cancer       Date:  2007-01-26       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.